Vaccination clinic begins Tuesday at MD...
Following receipt of the Pfizer COVID-19 vaccine on Monday morning, MD Anderson’s Pharmacy, Infection Control, Employee Health and clinical and facilities experts re-reviewed protocols and procedures, and an initial vaccination clinic simulation was completed. Based on those successful efforts along with a manager briefing and employee town hall, positive feedback from managers about employee engagement and swift uptake of...
Combination of chemotherapy and blinatumomab improves...
ABSTRACT 464
A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of...
MD Anderson welcomes 15 volunteer board members, honors two...
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) has named 15 new members and bestowed its highest honor of...
Patients with advanced BRCA-mutated breast cancer found no overall...
ABSTRACT: CTO71
New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center...
MD Anderson genetics expert Guillermina Lozano elected to...
Guillermina Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected as...
Study demonstrates liquid biopsy as effective predictor of...
A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was...
MD Anderson’s deemed status restored; re-accreditation completed
The University of Texas MD Anderson Cancer Center has announced that the Texas Health and Human Services Commission, on behalf of the...